Please use this identifier to cite or link to this item: https://doi.org/10.1517/14656566.6.11.1883
Title: Fluvastatin: Efficacy and safety in reducing cardiac events
Authors: Chan, M.Y.
Lee, C.H. 
Keywords: Clinical trials
Fluvastatin
Pharmacodynamics
Pharmacokinetics
Safety
Issue Date: Sep-2005
Citation: Chan, M.Y., Lee, C.H. (2005-09). Fluvastatin: Efficacy and safety in reducing cardiac events. Expert Opinion on Pharmacotherapy 6 (11) : 1883-1895. ScholarBank@NUS Repository. https://doi.org/10.1517/14656566.6.11.1883
Abstract: The importance of statin therapy in lipid-lowering and its role in primary and secondary prevention has been borne out of numerous clinical trials conducted over the last two decades. Concurrently, much concern has been expressed over the safety and tolerability of these drugs. Fluvastatin has demonstrated good clinical efficacy and safety. This paper reviews the various pharmacological properties and evidence supporting its use in the prevention of cardiac events. © 2005 Ashley Publications Ltd.
Source Title: Expert Opinion on Pharmacotherapy
URI: http://scholarbank.nus.edu.sg/handle/10635/133067
ISSN: 14656566
DOI: 10.1517/14656566.6.11.1883
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

3
checked on Nov 13, 2018

WEB OF SCIENCETM
Citations

3
checked on Oct 22, 2018

Page view(s)

22
checked on Nov 1, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.